{"disease":{"id":"burn-infection","name":"burn infection"},"drugs":{"marketed":[{"drug_id":"fusidic-acid","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ramycin","generic_name":"FUSIDIC ACID","company_name":"","drug_phase":"phase_3","molecular_target":"Bile salt export pump","drug_class":"fusidic acid","quality_score":47,"revenue":null,"mechanism":"Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins."},{"drug_id":"gentamicin","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Garamycin","generic_name":"GENTAMICIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Transient receptor potential cation channel subfamily V member 5","drug_class":"Aminoglycoside Antibacterial","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"erythromycin-ethyl-succinate","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eryped","generic_name":"Erythromycin ethyl succinate","company_name":"Arbor Pharms Llc","drug_phase":"marketed","molecular_target":"","drug_class":"Macrolide","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"sulfadiazine","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sulfadiazine","generic_name":"SULFADIAZINE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Sulfonamide Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"gentamicin-sulfate","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Gentamicin","generic_name":"Gentamicin Sulfate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Dihydrofolate reductase","drug_class":"gentamicin","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"amikacin","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Arikayce Kit","generic_name":"AMIKACIN","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"","drug_class":"Aminoglycoside Antibacterial","quality_score":10,"revenue":null,"mechanism":"Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria."},{"drug_id":"kanamycin","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Kanacin","generic_name":"KANAMYCIN","company_name":"Bristol-Myers Squibb","drug_phase":"marketed","molecular_target":"Gap junction beta-2 protein","drug_class":"Aminoglycoside Antibacterial","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"silvadene","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Silvadene","generic_name":"Silver Sulfadiazine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"bacterial cell membrane and cell wall","drug_class":"sulfonamide antimicrobial","quality_score":10,"revenue":null,"mechanism":"Silver sulfadiazine acts on bacterial cell membrane and cell wall to produce bactericidal effect."},{"drug_id":"mafenide","indication_name":"Burn Wound Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sulfamylon","generic_name":"MAFENIDE","company_name":"Rising","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 12","drug_class":"Methylated Sulfonamide Antibacterial","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":9,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05247333","title":"Implementation of a Minor Ailment Service in Community Pharmacy Practice","phase":"NA","overall_status":"COMPLETED","enrollment_count":20987,"lead_sponsor_name":"Universidad de Granada","has_results":false},{"nct_id":"NCT05394051","title":"Psychological Well-being and Burnout in Healthcare Workers During the COVID-19 (Coronavirus Disease 2019) Pandemic","phase":"NA","overall_status":"COMPLETED","enrollment_count":555,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT06221761","title":"A Study on the Prophylactic Use of Antibiotics Within 72 Hours After Acute Burn Injury in Patients","phase":"NA","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT03681678","title":"Laser Therapy for Treatment of Urogenital Symptoms in Women","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Corewell Health East","has_results":true},{"nct_id":"NCT07494773","title":"Topical Methylene Blue-Photodynamic Therapy (MB-PDT) for Burn Wound Infection","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Oklahoma","has_results":false},{"nct_id":"NCT04753723","title":"The Use of a Platform Wound Device for Reducing Infection","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"The Metis Foundation","has_results":false},{"nct_id":"NCT04516148","title":"A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Medstar Health Research Institute","has_results":false},{"nct_id":"NCT05167461","title":"AutoMated BUrn Diagnostic System for Healthcare (AMBUSH)","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT06391177","title":"A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Phathom Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04502914","title":"The Study on Bacterial Load Following Open-to-air Management in Burn Patients.","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Texas Tech University Health Sciences Center","has_results":false},{"nct_id":"NCT03816384","title":"Effect of Active Drain Line Clearance on Catheter-Associated Bacteriuria","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Potrero Medical","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}